- Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor
-
Jang JW
- KMID: 1381460
- Korean J Hepatol.
- 2008 Sep;14(3):305-308.
- doi: 10.3350/kjhep.2008.14.3.305
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis
-
Park YM, Choi JY, Byun BH, Cho CH, Kim HS, Kim BS
- KMID: 754985
- Exp Mol Med.
- 1998 Mar;30(1):35-40.
Telomerase is highly activated in human immortal cell lines and tumor tissues, whereas it is not activated in primary cell strains and many tumor-adjacent tissues. It is suggested that telomerase activation is... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma
-
Huh K, Choi SY, Whang YS, Lee DS
- KMID: 1745555
- J Korean Med Sci.
- 1998 Jun;13(3):306-310.
- doi: 10.3346/jkms.1998.13.3.306
The positive rates of hepatitis B surface antigen (HBsAg) and antibody to hepatitis C virus (anti-HCV) were analyzed according to year, sex, age, and serum ALT levels in 1,370... -
- CITED
-
- Close
- SHARE
-
- Close
- Newer treatments for advanced hepatocellular carcinoma
-
Song MJ, Bae SH
- KMID: 1792028
- Korean J Intern Med.
- 2014 Mar;29(2):149-155.
- doi: 10.3904/kjim.2014.29.2.149
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The only curative treatment modalities for HCC are surgery, percutaneous ablation, and liver transplantation. Unfortunately, the majority of patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases
-
Han CJ, Lee HS, Kim HS, Choe JH, Kim CY
- KMID: 1038875
- Korean J Intern Med.
- 1997 Jan;12(1):21-27.
OBJECTIVES: The relationship between HCV genotype and the development of more serious liver disease has not been clearly established. This study was to investigate the distribution pattern of HCV genotypes... -
- CITED
-
- Close
- SHARE
-
- Close
- Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor
-
Song IH, Kim DW, Shin KC, Shin HD, Yun SY, Kim SB, Shin JE, Kim HJ, Kim EY
- KMID: 1381465
- Korean J Hepatol.
- 2008 Sep;14(3):351-359.
- doi: 10.3350/kjhep.2008.14.3.351
BACKGROUND/AIMS: Cyclooxygenase-2 (COX-2) inhibitors reportedly inhibit the growth of hepatocellular carcinoma (HCC) via caspase-dependent or caspase-independent apoptosis, which is due to COX-2 being associated with hepatocarcinogenesis. Survivin is highly... -
- CITED
-
- Close
- SHARE
-
- Close
